Guo‐Hua Chu

945 total citations
28 papers, 627 citations indexed

About

Guo‐Hua Chu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Guo‐Hua Chu has authored 28 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Guo‐Hua Chu's work include Circadian rhythm and melatonin (6 papers), Receptor Mechanisms and Signaling (6 papers) and Estrogen and related hormone effects (4 papers). Guo‐Hua Chu is often cited by papers focused on Circadian rhythm and melatonin (6 papers), Receptor Mechanisms and Signaling (6 papers) and Estrogen and related hormone effects (4 papers). Guo‐Hua Chu collaborates with scholars based in United States, China and France. Guo‐Hua Chu's co-authors include Pui‐Kai Li, Donglu Bai, Xing‐Zu Zhu, Rui Xu, Kyle W. Selcer, Stefano Mangani, Cecilia Pozzi, Daniel C. Pevear, Daniel McGarry and Robert E. Lee Trout and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Guo‐Hua Chu

28 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo‐Hua Chu United States 13 295 236 180 124 97 28 627
Barry S. Orlek United Kingdom 15 430 1.5× 459 1.9× 181 1.0× 138 1.1× 44 0.5× 38 881
Gerardo D. Francisco United States 10 186 0.6× 189 0.8× 53 0.3× 61 0.5× 29 0.3× 16 389
R. A. DAINES United States 14 363 1.2× 598 2.5× 53 0.3× 247 2.0× 22 0.2× 25 961
Hyunshun Shin United States 7 208 0.7× 86 0.4× 63 0.3× 28 0.2× 39 0.4× 12 439
Renjian Zheng United States 18 613 2.1× 61 0.3× 63 0.3× 33 0.3× 53 0.5× 27 777
Karen Collins United States 18 340 1.2× 315 1.3× 20 0.1× 178 1.4× 6 0.1× 26 820
Valentina Straniero Italy 15 227 0.8× 179 0.8× 79 0.4× 57 0.5× 57 0.6× 33 491
Simon Ward United Kingdom 14 344 1.2× 38 0.2× 25 0.1× 69 0.6× 58 0.6× 25 561
Nelson Huang United States 9 211 0.7× 128 0.5× 74 0.4× 169 1.4× 7 0.1× 12 561
Futoshi Matsubara Japan 11 256 0.9× 36 0.2× 47 0.3× 33 0.3× 20 0.2× 20 570

Countries citing papers authored by Guo‐Hua Chu

Since Specialization
Citations

This map shows the geographic impact of Guo‐Hua Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Hua Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Hua Chu more than expected).

Fields of papers citing papers by Guo‐Hua Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Hua Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Hua Chu. The network helps show where Guo‐Hua Chu may publish in the future.

Co-authorship network of co-authors of Guo‐Hua Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Hua Chu. A scholar is included among the top collaborators of Guo‐Hua Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Hua Chu. Guo‐Hua Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bin, Robert E. Lee Trout, Guo‐Hua Chu, et al.. (2019). Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections. Journal of Medicinal Chemistry. 63(6). 2789–2801. 219 indexed citations
2.
Chu, Guo‐Hua, Bertrand Le Bourdonnec, Minghua Gu, et al.. (2009). Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors. PubMed. 3(1). 8–13. 8 indexed citations
3.
Bourdonnec, Bertrand Le, Karin Worm, Catherine Goodman, et al.. (2009). Novel sulfamoyl benzamides as selective CB2 agonists with improved in vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters. 20(1). 387–391. 9 indexed citations
4.
Chu, Guo‐Hua, Christopher T. Saeui, Karin Worm, et al.. (2009). Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(20). 5931–5935. 12 indexed citations
5.
Bourdonnec, Bertrand Le, Lara K. Leister, Joel Cassel, et al.. (2007). Discovery of a series of aminopiperidines as novel iNOS inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 336–343. 9 indexed citations
6.
Chu, Guo‐Hua, Minghua Gu, Joel Cassel, et al.. (2007). Novel malonamide derivatives as potent κ opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(7). 1951–1955. 24 indexed citations
7.
Chu, Guo‐Hua, Minghua Gu, Joel Cassel, et al.. (2005). Novel phenylamino acetamide derivatives as potent and selective κ opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(3). 645–648. 7 indexed citations
8.
Chu, Guo‐Hua, Minghua Gu, Joel Cassel, et al.. (2005). Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraints. Bioorganic & Medicinal Chemistry Letters. 15(23). 5114–5119. 21 indexed citations
9.
Chu, Guo‐Hua, Minghua Gu, Baudouin Gerard, & Roland E. Dolle. (2004). Development of a New α‐Aminonitrile Synthesis. Synthetic Communications. 34(24). 4583–4590. 2 indexed citations
10.
Chu, Guo‐Hua, et al.. (1999). Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 68(1-2). 31–40. 31 indexed citations
11.
Chu, Guo‐Hua, et al.. (1999). Synthesis and sulfatase inhibitory activities of (E)- and (Z)-4-hydroxytamoxifen sulfamates. Bioorganic & Medicinal Chemistry Letters. 9(2). 141–144. 18 indexed citations
12.
Chu, Guo‐Hua, et al.. (1998). Synthesis of 17-oxoandrosta-3,5-dien-3-methyl Sulfonate as Stable Analog of Dehydroepiandrosterone Sulfate. Steroids. 63(4). 214–217. 3 indexed citations
13.
Li, Pui‐Kai, et al.. (1998). Development of potent non-estrogenic estrone sulfatase inhibitors. Steroids. 63(7-8). 425–432. 46 indexed citations
14.
Chu, Guo‐Hua, Shawn K. Milano, Michael E. Rhodes, et al.. (1997). Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors. Steroids. 62(7). 530–535. 19 indexed citations
15.
Chu, Guo‐Hua & Pui‐Kai Li. (1997). Synthesis of sodium androst-5-ene-17-one-3β-methylene sulfonate. Steroids. 62(7). 543–545. 4 indexed citations
16.
Li, Pui‐Kai, et al.. (1997). Synthesis and receptor binding studies of quinolinic derivatives as melatonin receptor ligands. Bioorganic & Medicinal Chemistry Letters. 7(17). 2177–2180. 10 indexed citations
17.
Solladié, Guy & Guo‐Hua Chu. (1996). Total synthesis of (+)-Indolizidine 195 B and (+)-Monomorine. Tetrahedron Letters. 37(1). 111–114. 25 indexed citations
18.
Xu, Rui, et al.. (1996). Synthesis and analgesic activity of Epibatidine analogues. Bioorganic & Medicinal Chemistry Letters. 6(3). 279–282. 20 indexed citations
19.
Bai, Donglu, Rui Xu, Guo‐Hua Chu, & Xing‐Zu Zhu. (1996). Synthesis of (±)-Epibatidine and Its Analogues. The Journal of Organic Chemistry. 61(14). 4600–4606. 75 indexed citations
20.
Chu, Guo‐Hua, et al.. (1993). The total synthesis of sarmentosin, a potent GPT lowering agent. Bioorganic & Medicinal Chemistry Letters. 3(6). 1343–1344. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry S. Orlek Breakdown of academic impact, for papers by Gerardo D. Francisco Breakdown of academic impact, for papers by R. A. DAINES Breakdown of academic impact, for papers by Hyunshun Shin Breakdown of academic impact, for papers by Renjian Zheng Breakdown of academic impact, for papers by Karen Collins Breakdown of academic impact, for papers by Valentina Straniero Breakdown of academic impact, for papers by Simon Ward Breakdown of academic impact, for papers by Nelson Huang Breakdown of academic impact, for papers by Futoshi Matsubara
Rankless by CCL
2026